Advisor Group’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
Advisor Group's BLUE Position: Q4 2019 in Review
Advisor Group increased its bluebird bio (BLUE) stake by 144% in Q4 2019, buying an estimated $142K and bringing the position to 222 shares worth $251K. The position accounts for ﹤0.01% of the portfolio, ranked #2206.
Advisor Group first reported a position in BLUE in Q2 2016 and has held it in 15 quarters since. The position peaked at $510K in Q4 2017. 274 funds tracked by Wall St. Rank hold BLUE as of Q4 2019.
- Advisor Group held 222 shares of bluebird bio worth $251K as of Q4 2019.
- Advisor Group bought 131 bluebird bio shares in Q4 2019, an estimated $142K.
- bluebird bio made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #2206 holding.
- Advisor Group first reported a position in bluebird bio in Q2 2016 and has held it in 15 quarters since.
- Advisor Group's bluebird bio position peaked at $510K in Q4 2017.
- 274 funds tracked by Wall St. Rank held bluebird bio as of Q4 2019.
Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.